Determinants of the membrane orientation of a calcium signaling enzyme CD38

被引:30
|
作者
Zhao, Yong Juan [1 ,2 ]
Zhu, Wen Jie [1 ]
Wang, Xian Wang [3 ]
Zhang, Li-He [1 ,4 ]
Lee, Hon Cheung [1 ]
机构
[1] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Shenzhen, Peoples R China
[2] Univ Hong Kong, Dept Physiol, Pokfulam, Hong Kong, Peoples R China
[3] Yangtze Univ, Sch Med, Funct Lab, Jingzhou, Hubei, Peoples R China
[4] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2015年 / 1853卷 / 09期
基金
美国国家科学基金会;
关键词
CD38; Cyclic ADP-ribose; Membrane topology; ADP-ribosyl cyclase; Calcium signaling; CYCLIC-ADP-RIBOSE; CRYSTAL-STRUCTURE; TOPOLOGY; CYCLASE; ACID; CA2+; PHOSPHORYLATION; TRANSMEMBRANE; METABOLITE; RELEASE;
D O I
10.1016/j.bbamcr.2014.10.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD38 catalyzes the synthesis of two structurally distinct messengers for Ca2+-mobilization, cyclic ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP), from cytosolic substrates, NAD and NADP, respectively. CD38 is generally thought of as a type II membrane protein with its catalytic site facing outside. We recently showed that CD38 exists, instead, in two opposite membrane orientations. The determinant for the membrane topology is unknown. Here, specific antibodies against type III CD38 were designed and produced. We show that mutating the positively charged residues in the N-terminal tail of CD38 converted its orientation to type III, with the catalytic domain facing the cytosol and it was fully active in producing intracellular cADPR. Changing the serine residues to aspartate, which is functionally equivalent to phosphotylation, had a similar effect. The mutated CD38 was expressed intracellularly and was un-glycosylated. The membrane topology could also be modulated by changing the highly conserved di-cysteine. The results indicate that the net charge of the N-terminal segment is important in determining the membrane topology of CD38 and that the type III orientation can be a functional form of CD38 for Ca2+-signaling. This article is part of a Special Issue entitled: 13th European Symposium on Calcium. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:2095 / 2103
页数:9
相关论文
共 50 条
  • [21] Covalent and Noncovalent Intermediates of an NAD Utilizing Enzyme, Human CD38
    Liu, Qun
    Kriksunov, Irina A.
    Jiang, Hong
    Graeff, Richard
    Lin, Hening
    Lee, Hon Cheung
    Hao, Quan
    CHEMISTRY & BIOLOGY, 2008, 15 (10): : 1068 - 1078
  • [22] CD38: an ecto-enzyme with functional diversity in T cells
    Ghosh, Alip
    Khanam, Arshi
    Ray, Krishanu
    Mathur, Poonam
    Subramanian, Ananya
    Poonia, Bhawna
    Kottilil, Shyam
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [23] CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscle
    Deshpande, DA
    White, TA
    Dogan, S
    Walseth, TF
    Panettieri, RA
    Kannan, MS
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2005, 288 (05) : L773 - L788
  • [24] The metamorphosis of a molecule: from soluble enzyme to the leukocyte receptor CD38
    Ferrero, E
    Malavasi, F
    JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (02) : 151 - 161
  • [25] CD38/cADPR Signaling Pathway in Airway Disease: Regulatory Mechanisms
    Deshpande, Deepak A.
    Guedes, Alonso G. P.
    Graeff, Richard
    Dogan, Soner
    Subramanian, Subbaya
    Walseth, Timothy F.
    Kannan, Mathur S.
    MEDIATORS OF INFLAMMATION, 2018, 2018
  • [26] Conformational Closure of the Catalytic Site of Human CD38 Induced by Calcium
    Liu, Qun
    Graeff, Richard
    Kriksunov, Irina A.
    Lam, Connie M. C.
    Lee, Hon Cheung
    Hao, Quan
    BIOCHEMISTRY, 2008, 47 (52) : 13966 - 13973
  • [27] Functional associations of CD38 with CD3 on the T-cell membrane
    Reinis, M
    Morra, M
    Funaro, A
    Di Primio, R
    Malavasi, F
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1997, 11 (04): : 137 - 142
  • [28] CD38 as immunomodulator in cancer
    Li, Yanli
    Yang, Rui
    Chen, Limo
    Wu, Sufang
    FUTURE ONCOLOGY, 2020, 16 (34) : 2853 - 2861
  • [29] CD38 in health and disease
    Bofill, M
    Borthwick, NJ
    HUMAN CD38 AND RELATED MOLECULES, 2000, 75 : 218 - 234
  • [30] CD38 as a Therapeutic Target
    George T Stevenson
    Molecular Medicine, 2006, 12 : 345 - 346